查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1776221

神經血管血栓清除裝置/腦血栓清除裝置的全球市場 - 市場考察，競爭情形，市場預測(2032年)

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格
2024 年，全球神經血管血栓切除器械/腦血栓切除器械市場規模為 8.497 億美元，預計到 2032 年將達到 14.3478 億美元，2025 年至 2032 年的複合年增長率為 6.88%。神經系統疾病（尤其是中風）的負擔日益加重，大大推動了神經血管血栓切除器械市場的發展。同時，高血壓、糖尿病和肥胖症的發生率上升進一步加劇了中風和其他神經系統疾病的風險。這些疾病是中風的已知危險因素，並導致急性缺血事件的高發生率，從而促使對血栓切除器械的需求增加。然而，人們對機械血栓切除設備的認識和採用不斷提高，進一步推動了市場的發展。此外，市場的主要參與者正在持續投資研發，以推出創新的神經血管血栓切除/腦血栓切除設備。合作夥伴關係的加強、產品的推出以及監管部門的審批，將確保市場在預測期（2025-2032）內保持活力和創新。

神經血管血栓切除/腦血栓切除設備市場動態

根據英國心臟基金會（2025 年）提供的最新數據，約有 4,600 萬名女性和 4,800 萬名男性曾經中風。

根據世界中風組織（2025 年）的最新數據，每年約有 1,220 萬例新發生中風病例。在全球範圍內，四分之一的 26 歲及以上人群在其一生中會患上中風。

隨著中風患者數量的不斷增加，醫院和專科治療中心擴大採用這些設備作為恢復血液流動的救命解決方案。神經血管血栓切除術設備旨在清除阻塞腦血管的血栓，在急性缺血性中風的管理中至關重要，快速介入對於最大限度地減少腦損傷和改善患者預後至關重要。因此，中風患者數量的快速成長正在推動整個神經血管血栓切除術設備市場的成長，並凸顯這些設備在應對重大醫療課題中發揮的關鍵作用。

此外，根據世界衛生組織 (WHO) (2024) 提供的數據和統計，到 2022 年，全球八分之一的人將患有肥胖症。約有 25 億 18 歲及以上成年人超重，其中 8.9 億人將患有肥胖症。在18歲及以上的成年人中，43%超重，16%患有肥胖症。此外，到2022年，將有3,700萬五歲以下兒童超重。年齡較大的兒童和青少年中，超重的盛行率也很高，5至19歲之間的超重人群超過3.9億，其中1.6億人患有肥胖症。

肥胖是多種血管疾病的已知風險因素，包括缺血性中風（血栓阻塞腦血管時發生）。隨著全球肥胖率的上升，中風及其他相關併發症的盛行率也上升。患者數量的增加推動了對神經血管血栓切除術設備的需求，這種設備用於清除腦血栓並恢復正常血流，擴大了整體市場。

此外，神經血管血栓切除術/腦血栓切除術器械市場的成功發展將進一步推動全球整體市場的發展。例如，2025年4月，領先的醫療設備和體外診斷技術供應商Surmodics, Inc.宣布推出Pounce™ XL血栓切除系統，這是其Pounce™系列產品的另一個補充。該系統旨在快速從週邊動脈血管內清除急性或慢性血栓，進一步增強公司在血管介入領域的產品組合。

上述因素可能在預測期內推動神經血管血栓切除器械/腦血栓切除器械市場的發展。

然而，血管穿孔、栓塞和周邊腦組織損傷等併發症的風險，以及產品審批方面嚴格的監管問題，可能會阻礙神經血管血栓切除器械/腦血栓切除器械未來市場的發展。

本報告對全球神經血管血栓切除器械/腦血栓切除器械市場進行了研究和分析，提供了市場規模和預測、過去三年的產品和技術發展、主要市場參與者以及可用機會等資訊。

目錄

第1章 神經血管血栓清除裝置/腦血栓清除裝置市場報告的簡介

第2章 神經血管血栓清除裝置/腦血栓清除裝置市場摘要整理

  • 市場概要

第3章 競爭情形

第4章 法規分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第5章 神經血管血栓清除裝置/腦血栓清除裝置市場主要原因的分析

  • 神經血管血栓清除裝置/腦血栓清除裝置市場促進因素
  • 神經血管血栓清除裝置/腦血栓清除裝置市場阻礙因素與課題
  • 神經血管血栓清除裝置/腦血栓清除裝置市場機會

第6章 神經血管血栓清除裝置/腦血栓清除裝置市場波特的五力分析

第7章 神經血管血栓清除裝置/腦血栓清除裝置市場評估

  • 各產品類型
    • 血栓取出器
    • 血栓摘取支架
    • 吸引設備
    • 其他
  • 各功能
    • 機械性非吸引
    • 機械性吸引
  • 各用途
    • 末稍血管血栓消除
    • 冠狀動脈血栓消除
    • 神經血管血栓消除
  • 各終端用戶
    • 醫院·診療所
    • 門診病人手術中心
  • 地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 神經血管血栓清除裝置/腦血栓清除裝置市場企業與產品的簡介

  • Stryker
  • Penumbra, Inc.
  • Vesalio, LLC.
  • Acandis GmbH
  • Rapid Medical
  • Johnson & Johnson
  • Teleflex Incorporated
  • Medtronic PLC
  • NeuroVasc Technologies, Inc.
  • Perflow Medical
  • Edward LifeSciences Corporation
  • Terumo Europe NV
  • Koninklijke Philips N.V.
  • MicroVention Inc.
  • Phenox GmbH
  • Biomedical Solutions Inc.
  • Ceretrieve Ltd.
  • Anaconda Biomed SL
  • Genesis Medtech
  • Innova Vascular

第9章 KOL的見解

第10章 計劃方法

第11章 關於DelveInsight

第12章 免責聲明與聯絡處

Product Code: DIMDCL0102

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market by Product Type (Clot Retrievers, Stent Retrievers, Aspiration Devices, and Others), Function (Mechanical Non-aspiration and Mechanical Aspiration), Application (Peripheral Vascular Thrombectomy, Coronary Vascular Thrombectomy, and Neurovascular Thrombectomy), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising burden of neurological disorders such as stroke, increase in cases of hypertension, diabetes, obesity, growing awareness and adoption of mechanical thrombectomy, and increase in product launches and approvals by key market players across the globe.

The neurovascular thrombectomy devices/neurothrombectomy devices market was valued at USD 849.70 million in 2024, growing at a CAGR of 6.88% during the forecast period from 2025 to 2032 to reach USD 1,434.78 million by 2032. The rising burden of neurological disorders, particularly stroke, is significantly boosting the market for neurovascular thrombectomy devices as these are the medical instruments used to remove blood clots from the blood vessels in the brain. Concurrent with this, the rise in cases of hypertension, diabetes, and obesity further exacerbates the risk of stroke and other neurological disorders. These conditions are well-established risk factors for stroke, leading to a higher incidence of acute ischemic events and, consequently, an increased demand for thrombectomy devices. However, the growing awareness and adoption of mechanical thrombectomy devices have further boosted the market. Furthermore, key market players continuously investing in research and development to introduce innovative neurovascular thrombectomy devices/neurothrombectomy devices, increased partnerships and collaborations, product launches, and approvals ensure that the market remains dynamic and innovative, during the forecast period from 2025 to 2032.

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Dynamics:

According to the recent data provided by the British Heart Foundation (2025), around 46 million women and 48 million men were stroke survivors.

Additionally, as per the latest data provided by the World Stroke Organization (2025), approximately, 12.2 million new strokes occur each year. Globally, one in four people over age 25 will have a stroke in their lifetime.

The escalating number of stroke cases leads to greater adoption of these devices in hospitals and specialized treatment centers, as they offer a life-saving solution for restoring blood flow. Neurovascular thrombectomy devices, which are designed to remove clots obstructing brain blood vessels, become crucial in managing acute ischemic stroke, a condition where rapid intervention is essential to minimize brain damage and improve patient outcomes. As a result, the surge in stroke cases drives the overall growth of the neurovascular thrombectomy device market, highlighting the critical role these devices play in addressing a major healthcare challenge.

Additionally, as per the data and stats provided by the World Health Organization (2024), in 2022, 1 in 8 people worldwide were living with obesity. Approximately, 2.5 billion adults aged 18 years and older were overweight, with 890 million of them living with obesity. Among adults aged 18 years and over, 43% were overweight, and 16% were living with obesity. Additionally, 37 million children under the age of 5 were overweight in 2022. The prevalence of overweight was also significant among older children and adolescents, with over 390 million individuals aged 5-19 years being overweight, including 160 million who were living with obesity.

Obesity is a well-established risk factor for several vascular diseases, including ischemic stroke, which occurs when a blood clot obstructs a blood vessel in the brain. As the global obesity rates rise, there is a corresponding increase in the incidence of stroke and other related complications. This growing patient population drives demand for neurovascular thrombectomy devices, which are used to remove blood clots from the brain and restore normal blood flow thereby escalating the overall market.

Furthermore, the successful developmental activities in the neurovascular thrombectomy devices/neurothrombectomy devices market further boost the overall market across the globe. For instance, in April 2025, Surmodics, Inc., a leading provider of medical devices and in vitro diagnostic technologies to the healthcare industry, announced the commercial launch of the Pounce(TM) XL Thrombectomy System, an advanced addition to its Pounce(TM) suite. The system was designed to enable rapid endovascular removal of acute or chronic thrombus from peripheral arteries, further strengthening the company's portfolio in vascular intervention.

Thus, the factors mentioned above are likely to boost the market of neurovascular thrombectomy devices/neurothrombectomy devices during the forecasted period.

However, the risk of complications such as vessel perforation, embolism, or damage to surrounding brain tissue and stringent regulatory concerns for product approval may hinder the future market of neurovascular thrombectomy devices/neurothrombectomy devices.

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Segment Analysis:

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market by Product Type (Clot Retrievers, Stent Retrievers, Aspiration Devices, and Others), Function (Mechanical Non-aspiration and Mechanical Aspiration), Application (Peripheral Vascular Thrombectomy, Coronary Vascular Thrombectomy, and Neurovascular Thrombectomy), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the neurovascular thrombectomy devices/neurothrombectomy devices market, clot retrievers are projected to hold a considerable market share in 2024. Clot retrievers are significantly boosting the overall market of neurovascular thrombectomy devices by revolutionizing the treatment of ischemic strokes. These devices, designed to mechanically remove blood clots from the brain's blood vessels, have enhanced the efficacy of thrombectomy procedures. Their advanced design and functionality enable more effective and reliable clot retrieval, which improves patient outcomes and increases the likelihood of complete recanalization of obstructed vessels. This has led to a broader adoption of thrombectomy as a standard treatment for acute ischemic stroke, thereby driving demand for these devices. The success of clot retrievers has also spurred innovation, leading to the development of newer, more sophisticated models with improved performance characteristics.

Additionally, clinical studies demonstrating the benefits of clot retrievers in reducing disability and mortality have increased their acceptance among healthcare professionals, further contributing to market growth. As more hospitals and stroke centers adopt these technologies, the market for neurovascular thrombectomy devices expands, driven by the increased emphasis on timely and effective stroke intervention.

This growth is also supported by ongoing research and development efforts, and other product development activities across the globe which continue to refine and enhance clot retrieval technologies, ensuring their continued relevance and effectiveness in stroke care. For instance, in June 2023, Innova Vascular received FDA clearance for two new thrombectomy devices Laguna Clot Retriever(TM) System and the Malibu Aspiration Catheter(TM) System. This system is indicated for non-surgical removal of emboli or thrombi, and/or infusing, injecting, or aspirating fluids into or from blood vessels in the peripheral vasculature.

Therefore, owing to the above-mentioned factors, the clot retriever category is expected to generate considerable revenue thereby pushing the overall growth of the global neurovascular thrombectomy devices/neurothrombectomy devices market during the forecast period.

North America is expected to dominate the overall neurovascular thrombectomy devices/neurothrombectomy devices market:

North America is expected to account for the highest proportion of the neurovascular thrombectomy devices/neurothrombectomy devices market in 2024, out of all regions. This can be ascribed to the increasing prevalence of stroke, obesity, hypertension, diabetes, and others, increased government initiatives coupled with increased awareness programs for neurovascular disease, and the presence of key market players engaged in merger, acquisition, product launches, and other market activities across the region are expected to escalate the market of neurovascular thrombectomy devices/neurothrombectomy devices.

According, to the latest data provided by the Centre for Disease Control and Prevention (2024), in the United States, a stroke occurs every 40 seconds, with more than 795,000 people experiencing a stroke annually. Of these, approximately 610,000 were first or new strokes, while around 185,000, or nearly 1 in 4, involved individuals had a previous stroke. Ischemic strokes, which result from blocked blood flow to the brain, accounted for about 87% of all stroke cases.

Additionally, as per the recent data provided by the Centre for Disease Control and Prevention (2024), nearly half of the adults in the United States, totaling 116 million, had hypertension, with the majority 92.1 million having their condition not under control.

Furthermore, as per the recent data provided by the Centre for Disease Control and Prevention (2024), approximately, 38.4 million people of all ages, representing 11.6% of the U.S. population, had diabetes.

Diabetes and hypertension are major risk factors for stroke, leading to an increased demand for effective treatments to manage and mitigate these risks. Neurovascular thrombectomy devices, which are used to remove blood clots from the brain's blood vessels, become increasingly critical as the incidence of stroke rises. This growing demand for thrombectomy procedures drives the market for these devices, as healthcare providers seek advanced tools to enhance patient outcomes and reduce the impact of strokes. Consequently, the prevalence of diabetes and hypertension directly contributes to the market expansion of neurovascular thrombectomy devices across the region.

Moreover, the increase in product development activities and ongoing research and development further escalates the market of neurovascular thrombectomy devices/neurothrombectomy devices across the region. For instance, in February 2024, Innova Vascular announced the successful early commercial use of Laguna Thrombectomy System(TM) in patients.

Therefore, the above-mentioned factors are expected to bolster the growth of the neurovascular thrombectomy devices/neurothrombectomy devices market in North America during the forecast period.

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Key Players:

Some of the key market players operating in the neurovascular thrombectomy devices/neurothrombectomy devices market include Stryker, Penumbra, Inc., Vesalio, LLC., Acandis GmbH, Rapid Medical, Johnson & Johnson Services Inc., Teleflex Incorporated, Medtronic, NeuroVasc Technologies, Inc., Perflow Medical, Edward LifeSciences Corporation, Terumo Corporation, Koninklijke Philips N.V., MicroVention Inc., phenox GmbH, Biomedical Solutions Inc., Ceretrieve Ltd., Anaconda Biomed SL, Genesis Medtech., Innova Vascular, and others.

Recent Developmental Activities in the Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market:

  • In February 2023, Phenox Inc. received FDA 510(k) clearance for its pRESET(R) Thrombectomy Device, a minimally invasive tool designed to remove blood clots in patients with acute ischemic stroke. This minimally invasive device is designed to effectively remove blood clots from blocked brain arteries, helping to rapidly restore blood flow and minimize brain damage.
  • In September 2022, Vesalio announced the CE Approval for the new NeVa NET(TM). NeVa Net(TM) micro-filtration technology is coupled with NeVa's Drop Zone(TM) technology which creates a one-of-a-kind stent retriever designed to capture every type of clot and maximize clot retention for fast and effective recanalization of ischemic tissue.

Key takeaways from the neurovascular thrombectomy devices/neurothrombectomy devices market report study:

  • Market size analysis for current neurovascular thrombectomy devices/neurothrombectomy devices size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the neurovascular thrombectomy devices/neurothrombectomy devices market.
  • Various opportunities available for the other competitors in the neurovascular thrombectomy devices/neurothrombectomy devices market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current neurovascular thrombectomy devices/neurothrombectomy devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for neurovascular thrombectomy devices/neurothrombectomy devices market growth in the coming future?

Target audience who can benefit from this neurovascular thrombectomy devices/neurothrombectomy devices market report study:

  • Neurovascular thrombectomy devices/neurothrombectomy devices product providers
  • Research organizations and consulting companies
  • Neurovascular thrombectomy devices/neurothrombectomy devices-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in neurovascular thrombectomy devices/neurothrombectomy devices
  • Various end-users who want to know more about the neurovascular thrombectomy devices/neurothrombectomy devices market and the latest technological developments in the neurovascular thrombectomy devices/neurothrombectomy devices market.

Frequently Asked Questions for the Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market:

1. What are neurovascular thrombectomy devices/neurothrombectomy devices?

  • Neurovascular thrombectomy devices, also known as cerebral thrombectomy devices, are used to remove or destroy blood clots in the brain region. These devices are also used in patients where pharmacological treatment has not worked effectively.

2. What is the market for neurovascular thrombectomy devices/neurothrombectomy devices?

  • The neurovascular thrombectomy devices/neurothrombectomy devices market was valued at USD 849.70 million in 2024, growing at a CAGR of 6.88% during the forecast period from 2025 to 2032 to reach USD 1,434.78 million by 2032.

3. What are the drivers for the neurovascular thrombectomy devices/neurothrombectomy devices market?

  • The rising burden of neurological disorders, particularly stroke, is significantly boosting the market for neurovascular thrombectomy devices as these are the medical instruments used to remove blood clots from the blood vessels in the brain. Concurrent with this, the rise in cases of hypertension, diabetes, and obesity further exacerbates the risk of stroke and other neurological disorders. These conditions are well-established risk factors for stroke, leading to a higher incidence of acute ischemic events and, consequently, an increased demand for thrombectomy devices. However, the growing awareness and adoption of mechanical thrombectomy devices have further boosted the market. Furthermore, key market players continuously investing in research and development to introduce innovative neurovascular thrombectomy devices/neurothrombectomy devices, increased partnerships and collaborations, product launches, and approvals ensure that the market remains dynamic and innovative, during the forecast period from 2025 to 2032.

4. Who are the key players operating in the neurovascular thrombectomy devices/neurothrombectomy devices market?

  • Some of the key market players operating in the neurovascular thrombectomy devices/neurothrombectomy devices market include Stryker, Penumbra, Inc., Vesalio, LLC., Acandis GmbH, Rapid Medical, Johnson & Johnson Services Inc., Teleflex Incorporated, Medtronic, NeuroVasc Technologies, Inc., Perflow Medical, Edward LifeSciences Corporation, Terumo Corporation, Koninklijke Philips N.V., MicroVention Inc., phenox GmbH, Biomedical Solutions Inc., Ceretrieve Ltd., Anaconda Biomed SL, Genesis Medtech, Innova Vascular, and others.

5. Which region has the highest share in the neurovascular thrombectomy devices/neurothrombectomy devices market?

  • North America is expected to account for the highest proportion of the neurovascular thrombectomy devices/neurothrombectomy devices market in 2024, out of all regions. This can be ascribed to the increasing prevalence of stroke, obesity, hypertension, diabetes, and others, increased government initiatives coupled with increased awareness programs for neurovascular disease, and the presence of key market players engaged in merger, acquisition, product launches, and other market activities across the region are expected to escalate the market of neurovascular thrombectomy devices/neurothrombectomy devices.

Table of Contents

1. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Key Factors Analysis

  • 5.1. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Drivers
    • 5.1.1. The rising burden of neurological disorders such as stroke
    • 5.1.2. Increase in cases of hypertension, diabetes, obesity
    • 5.1.3. Growing awareness and adoption of mechanical thrombectomy
    • 5.1.4. Increase in product launches and approvals by key market players across the globe.
  • 5.2. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Restraints and Challenges
    • 5.2.1. The risk of complications such as vessel perforation, embolism, or damage to surrounding brain tissue
    • 5.2.2. Stringent regulatory concerns for product approval
  • 5.3. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Opportunities
    • 5.3.1. Ongoing research and development in improving clot retrieval mechanisms and enhanced imaging integration

6. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Clot Retrievers
    • 7.1.2. Stent Retrievers
    • 7.1.3. Aspiration Devices
    • 7.1.4. Others
  • 7.2. By Function
    • 7.2.1. Mechanical Non-aspiration
    • 7.2.2. Mechanical Aspiration
  • 7.3. By Application
    • 7.3.1. Peripheral Vascular Thrombectomy
    • 7.3.2. Coronary Vascular Thrombectomy
    • 7.3.3. Neurovascular Thrombectomy
  • 7.4. By End-User
    • 7.4.1. Hospitals & Clinics
    • 7.4.2. Ambulatory Surgical Centers
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.1.2. Canada Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.1.3. Mexico Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
    • 7.5.2. Europe
      • 7.5.2.1. France Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.2.2. Germany Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.2.3. United Kingdom Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.2.4. Italy Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.2.5. Spain Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.2.6. Rest of Europe Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.3.2. Japan Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.3.3. India Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.3.4. Australia Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.3.5. South Korea Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.3.6. Rest of Asia-Pacific Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.4.2. Africa Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)
      • 7.5.4.3. South America Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Size in USD million (2022-2032)

8. Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market Company and Product Profiles

  • 8.1. Stryker
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Penumbra, Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Vesalio, LLC.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Acandis GmbH
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Rapid Medical
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Johnson & Johnson
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Teleflex Incorporated
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Medtronic PLC
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. NeuroVasc Technologies, Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Perflow Medical
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Edward LifeSciences Corporation
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Terumo Europe NV
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Koninklijke Philips N.V.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. MicroVention Inc.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Phenox GmbH
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Biomedical Solutions Inc.
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Ceretrieve Ltd.
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Anaconda Biomed SL
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Genesis Medtech
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Innova Vascular
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global (2022-2032)
  • Table 3: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global by Product Type (2022-2032)
  • Table 4: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global by Function (2022-2032)
  • Table 5: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global by Application (2022-2032)
  • Table 6: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global by End-User (2022-2032)
  • Table 7: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global by Geography (2022-2032)
  • Table 8: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in North America (2022-2032)
  • Table 9: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in the United States (2022-2032)
  • Table 10: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Canada (2022-2032)
  • Table 11: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Mexico (2022-2032)
  • Table 12: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Europe (2022-2032)
  • Table 13: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in France (2022-2032)
  • Table 14: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Germany (2022-2032)
  • Table 15: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in United Kingdom (2022-2032)
  • Table 16: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Italy (2022-2032)
  • Table 17: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Spain (2022-2032)
  • Table 18: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in the Rest of Europe (2022-2032)
  • Table 19: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Asia-Pacific (2022-2032)
  • Table 20: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in China (2022-2032)
  • Table 21: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Japan (2022-2032)
  • Table 22: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in India (2022-2032)
  • Table 23: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Australia (2022-2032)
  • Table 24: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in South Korea (2022-2032)
  • Table 25: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Rest of Asia-Pacific (2022-2032)
  • Table 26: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in the Rest of the World (2022-2032)
  • Table 27: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in the Middle East (2022-2032)
  • Table 28: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Africa (2022-2032)
  • Table 29: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global (2022-2032)
  • Figure 3: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global by Product Type (2022-2032)
  • Figure 4: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global by Function (2022-2032)
  • Figure 5: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global by Application (2022-2032)
  • Figure 6: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global by End-User (2022-2032)
  • Figure 7: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Global by Geography (2022-2032)
  • Figure 8: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in North America (2022-2032)
  • Figure 9: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in the United States (2022-2032)
  • Figure 10: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Canada (2022-2032)
  • Figure 11: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Mexico (2022-2032)
  • Figure 12: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Europe (2022-2032)
  • Figure 13: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in France (2022-2032)
  • Figure 14: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Germany (2022-2032)
  • Figure 15: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in United Kingdom (2022-2032)
  • Figure 16: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Italy (2022-2032)
  • Figure 17: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Spain (2022-2032)
  • Figure 18: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in the Rest of Europe (2022-2032)
  • Figure 19: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Asia-Pacific (2022-2032)
  • Figure 20: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in China (2022-2032)
  • Figure 21: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Japan (2022-2032)
  • Figure 22: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in India (2022-2032)
  • Figure 23: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Australia (2022-2032)
  • Figure 24: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in South Korea (2022-2032)
  • Figure 25: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Rest of Asia-Pacific (2022-2032)
  • Figure 26: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in the Rest of the World (2022-2032)
  • Figure 27: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in the Middle East (2022-2032)
  • Figure 28: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in Africa (2022-2032)
  • Figure 29: Neurovascular Thrombectomy Devices/Neurothrombectomy Devices Market in South America (2022-2032)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Market Opportunities
  • Figure 33: PORTER'S Five Force Analysis